|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 |
| (11) | Patento numeris | 2729172 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12748078.8 |
| Europos patento paraiškos padavimo data | 2012-07-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/045235 |
| Data | 2012-07-02 |
| (87) | Numeris | WO 2013/006547 |
| Data | 2013-01-10 |
| (30) | Numeris | Data | Šalis |
| 201161504633 P | 2011-07-05 | US | |
| 201161558945 P | 2011-11-11 | US |
| (72) |
BUKHALID, Raghida, US
FELDHAUS, Michael, US
KING, Anne, US
KOHLI, Neeraj, US
KRAULAND, Eric, US
KEARNS, Jeffrey, David, US
LUGOVSKOY, Alexey, A., US
NIELSEN, Ulrik, US
|
| (73) |
Merrimack Pharmaceuticals, Inc.,
One Kendall Square Suite B7201, Cambridge, MA 02139,
US
|
| (54) | ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF |
| ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF |